FEB 03, 2016 7:30 AM PST

Keynote: Vibration, Noise & Ultrasonic Noise From Vivarium and Lab Equipment as Rapidly Growing Confounds in Animal Research

Speaker
  • CEO, OtoScience Labs, Professor of Psychology, Illinois College
    Biography
      Jeremy Turner, PhD, is co-founder and CEO of OtoScience Labs, a company that conducts noise and vibration measurement, 24-hour monitoring services, and consulting for animal facilities. His research focuses on rat and mouse models of hearing, the impacts of noise on the ear and brain, and the neuroscience of hearing loss and tinnitus. His research has been supported by the United States National Institutes of Health, the Tinnitus Research Consortium, and most recently a grant from the US Department of Defense Psychological Health and Traumatic Brain Injury Program to OtoScience Labs.

    Abstract

    Noise and vibration are very effective activators of stress pathways in rodent models that can increase variability in animal models, thereby confounding virtually every area of biomedical and behavioral research. Noise and vibration in animal facilities is generally not well controlled, managed, or even monitored. With the introduction of more mechanical and technological sources of such noise and vibration in the vivarium space (e.g., IVC caging cage changing stations, computers) the potential impacts of these confounds are greater today than ever. In addition, much of the noise produced by such modern technology is in the ultrasonic range, which we human observers cannot hear, and the noise meters we typically use cannot measure. This talk will focus on the sources of such noise and vibration (IVC caging, animal transport, fluorescent lighting, computers, cage changing stations, lab equipment), why and how they should be measured and monitored, and what strategies administrators and staff can use to minimize or control them as confounds in biomedical research. This talk will also discuss practical steps for minimizing these confounds. Special emphasis will be placed on how these confounds introduce variability in our animal models, serving to hamper our goals of animal model reduction and refinement.


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    Loading Comments...
    Show Resources
    Attendees
    • See more